State Key Laboratory of Bioreactor Engineering, East China University of Science and Technologygrid.28056.39, Shanghai, China.
Southern Marine Science and Engineering Guangdong Laboratory (Zhuhai), Zhuhai, China.
Appl Environ Microbiol. 2021 Oct 14;87(21):e0146821. doi: 10.1128/AEM.01468-21. Epub 2021 Aug 18.
Aeromonas salmonicida is an aquatic pathogen that can infect a variety of fish. Phage therapy has been applied to treat bacterial infections. In this study, we obtained three subsp. phage isolates from sewage, and one phage (vB_AsM_ZHF) exhibited the best antibacterial effect, based on kinetics experiments. Sequencing indicated that the vB_AsM_ZHF genome is 161,887 bp (41.24% C+G content) with 237 predicted open reading frames. No antibiotic resistance or virulence genes were detected in the complete genome, which is a requirement for phage therapy safety. Intraperitoneal injection of phage vB_AsM_ZHF into turbot at 8 × 10 PFU/fish rescued turbot from subsp. injection and reduced the bacterial burden by 1 order of magnitude. Injection of vB_AsM_ZHF also decreased levels of inflammatory cell infiltration in muscle tissue, cytokines interleukin-1β (IL-1β), tumor necrosis factor alpha (TNF-α), and gamma interferon (IFN-γ) in serum and the expression of the inflammatory factors IL-1β, IL-6, IFN-γ, transforming growth factor β, TNF-α, and hepcidin in the liver, spleen, and head kidney of turbot. Phage vB_AsM_ZHF demonstrated antibacterial ability and and significantly reduced mortality in turbot challenged by subsp. . This study revealed that phage vB_AsM_ZHF can effectively treat the infection caused by subsp. in turbot. is an aquatic pathogen that can infect different fish and causes economic loss to the global aquaculture industry. Clinical strains of have developed multidrug resistance, and phage therapy is being evaluated for controlling bacterial infections. Phages are biological antibacterial agents and have the potential to be therapeutic agents against multidrug-resistant bacteria. In this study, three subsp. phages were isolated from sewage, and their biological behaviors were characterized. The newly isolated phage vB_AsM_ZHF could inhibit subsp. infection and , suggesting that it may be an alternative strategy to antibiotics for protecting fish against multidrug-resistant subsp. in the aquaculture industry.
嗜水气单胞菌是一种水生病原体,可以感染多种鱼类。噬菌体疗法已被应用于治疗细菌感染。在这项研究中,我们从污水中获得了三种亚种噬菌体分离株,其中一种噬菌体(vB_AsM_ZHF)在动力学实验中表现出最好的抗菌效果。测序表明,vB_AsM_ZHF 基因组长 161887bp(41.24% C+G 含量),包含 237 个预测的开放阅读框。在完整基因组中未检测到抗生素耐药或毒力基因,这是噬菌体治疗安全性的要求。将噬菌体 vB_AsM_ZHF 以 8×10PFU/鱼的剂量腹腔注射到大菱鲆中,可拯救因注射亚种而感染的大菱鲆,并将细菌负荷降低 1 个数量级。注射 vB_AsM_ZHF 还降低了肌肉组织中炎症细胞浸润、血清中白细胞介素 1β(IL-1β)、肿瘤坏死因子 α(TNF-α)和γ干扰素(IFN-γ)水平以及大菱鲆肝脏、脾脏和头肾中炎症因子 IL-1β、IL-6、IFN-γ、转化生长因子 β、TNF-α和铁调素的表达。噬菌体 vB_AsM_ZHF 表现出抗菌能力,并显著降低了大菱鲆亚种感染的死亡率。这项研究表明,噬菌体 vB_AsM_ZHF 可有效治疗大菱鲆亚种感染。是一种水生病原体,可以感染不同的鱼类,给全球水产养殖业造成经济损失。临床分离株已对多种药物产生耐药性,噬菌体疗法正在被评估用于控制细菌感染。噬菌体是生物抗菌剂,具有成为治疗多药耐药菌的治疗剂的潜力。在这项研究中,从污水中分离出三种亚种噬菌体,并对其生物学行为进行了表征。新分离的噬菌体 vB_AsM_ZHF 可以抑制亚种感染和,表明它可能是抗生素以外的另一种策略,用于保护鱼类免受水产养殖中多药耐药亚种的侵害。